1. Home
  2. BCRX vs GAB Comparison

BCRX vs GAB Comparison

Compare BCRX & GAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

HOLD

Current Price

$9.55

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo Gabelli Equity Trust Inc. (The)

GAB

Gabelli Equity Trust Inc. (The)

HOLD

Current Price

$5.69

Market Cap

1.7B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCRX
GAB
Founded
1986
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.7B
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
BCRX
GAB
Price
$9.55
$5.69
Analyst Decision
Strong Buy
Analyst Count
11
0
Target Price
$20.82
N/A
AVG Volume (30 Days)
5.5M
1.2M
Earning Date
05-06-2026
01-01-0001
Dividend Yield
N/A
10.91%
EPS Growth
381.40
N/A
EPS
N/A
N/A
Revenue
$25,186,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$12.55
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.00
$5.28
52 Week High
$10.94
$6.37

Technical Indicators

Market Signals
Indicator
BCRX
GAB
Relative Strength Index (RSI) 58.79 57.22
Support Level $8.04 $5.46
Resistance Level $10.04 $5.71
Average True Range (ATR) 0.49 0.10
MACD 0.13 0.02
Stochastic Oscillator 50.88 94.64

Price Performance

Historical Comparison
BCRX
GAB

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

About GAB Gabelli Equity Trust Inc. (The)

Gabelli Equity Trust Inc is a non-diversified closed-end management investment company. Its primary investment objective is the long-term growth of capital with income as a secondary objective. The Fund invests at least its assets in equity securities under normal market conditions. Its equity portfolio includes common stock, preferred stock, convertible or exchangeable securities, and warrants and rights to purchase such securities selected by the Investment Adviser. The company invests in various sectors, of which Food & Beverage, Financial Services, Equipment and Supplies, Entertainment, Consumer Products, Health Care, Diversified Industrial, Business Services, Consumer Services and others.

Share on Social Networks: